Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Andrew Mould

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Neurocritical Care|January 3, 2018
The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III TrialAchim Müller, W Andrew Mould, W David Freeman, et al.
Stroke|February 9, 2013
Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edemaW Andrew Mould, J Ricardo Carhuapoma, John Muschelli, et al.
Neurosurgery|April 13, 2017
Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical TrialMaged D Fam, Daniel Hanley, Agnieszka Stadnik, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 24, 2021
Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons LearnedAli Mansour, Andrea Loggini, Faten El Ammar, et al.
Clinical Therapeutics|August 2, 2022
Design and Protocol of the Renal Anhydramnios Fetal Therapy (RAFT) TrialMeredith A Atkinson, Eric B Jelin, Ahmet Baschat, et al.
Journal of Clinical and Translational Science|September 1, 2023
Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learnedDaniel F Hanley, Gordon R Bernard, Consuelo H Wilkins, et al.
Neurosurgery|January 21, 2021
Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH TrialsSean P Polster, Julián Carrión-Penagos, Seán B Lyne, et al.
The Lancet. Neurology|October 19, 2016
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialDaniel F Hanley, Richard E Thompson, John Muschelli, et al.
Contemporary Clinical Trials|December 28, 2022
Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experienceAngelique E Boutzoukas, Rachel Olson, Mary Ann Sellers, et al.
Lancet (London, England)|January 14, 2017
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trialDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Neurocritical Care|January 3, 2018
The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III TrialAchim Müller, W Andrew Mould, W David Freeman, et al.
Stroke|February 9, 2013
Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edemaW Andrew Mould, J Ricardo Carhuapoma, John Muschelli, et al.
Neurosurgery|April 13, 2017
Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical TrialMaged D Fam, Daniel Hanley, Agnieszka Stadnik, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 24, 2021
Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons LearnedAli Mansour, Andrea Loggini, Faten El Ammar, et al.
Clinical Therapeutics|August 2, 2022
Design and Protocol of the Renal Anhydramnios Fetal Therapy (RAFT) TrialMeredith A Atkinson, Eric B Jelin, Ahmet Baschat, et al.
Journal of Clinical and Translational Science|September 1, 2023
Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learnedDaniel F Hanley, Gordon R Bernard, Consuelo H Wilkins, et al.
Neurosurgery|January 21, 2021
Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH TrialsSean P Polster, Julián Carrión-Penagos, Seán B Lyne, et al.
The Lancet. Neurology|October 19, 2016
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialDaniel F Hanley, Richard E Thompson, John Muschelli, et al.
Contemporary Clinical Trials|December 28, 2022
Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experienceAngelique E Boutzoukas, Rachel Olson, Mary Ann Sellers, et al.
Lancet (London, England)|January 14, 2017
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trialDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Pageof 3